Abstract
Non-immediate allergic cutaneous reactions to heparins have been increasingly reported, typically manifesting as large, eczematous plaques at sites of subcutaneous injection. Patients may demonstrate cross-reactivity between unfractionated heparin, low molecular weight heparin and semi-synthetic heparinoids, making finding an alternative difficult. Fondaparinux has been identified as a useful alternative in such patients; here we present the first two documented cases in Australia and a literature review.
Original language | English |
---|---|
Pages (from-to) | 73-77 |
Number of pages | 5 |
Journal | Internal Medicine Journal |
Volume | 48 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2018 |